YWYu Wang

Yu Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yu Wang has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Causal Association Between Commonly Used Medicines and Diabetes‐Related Eye Diseases: Univariable and Multivariable Mendelian Randomization Study

    by Yu Wang, Chak Kwong Cheng, Lamusi A., Mingyue Jin, Chang Wang

    Background: Diabetic patients require long‐term polypharmacy, yet the causal effects of these medications on ocular complications—specifically diabetic retinopathy (DR), diabetic maculopathy (DMac), and glaucoma—remain unclear due to confounding in observational studies. Methods: We performed a Mendelian randomization (MR) study using GWAS summary statistics for 23 common medication classes and five diabetic eye diseases. Multivariable MR (MVMR) was employed to adjust for key comorbidities (e.g., hypertension, type 2 diabetes), while enrichment analyses explored biological mechanisms. Results: In the univariable MR (UVMR) analysis, drugs used in diabetes, agents acting on the renin–angiotensin system, and several other medication classes showed significant associations with increased risks of diabetic eye diseases. Crucially, MVMR confirmed robust causal links after adjusting for key comorbidities. Specifically, drugs used in diabetes remained associated with DMac (OR = 1.44, p = 1.31 × 10 −11 ), DR (OR = 1.23, p = 1.26 × 10 −8 ), neovascular glaucoma (OR = 1.19, p = 0.003), and senile cataract (OR = 1.10, p = 9.25 × 10 −12 ) independent of type 2 diabetes liability. Similarly, thyroid preparations retained significance for DMac (OR = 1.26, p = 4.35 × 10 −10 ), DR (OR = 1.17, p = 9.53 × 10 −10 ), and senile cataract (OR = 1.04, p = 0.004) after adjusting for hypothyroidism. Additionally, adrenergic inhalants were independently linked to senile cataract (OR = 1.07, p = 0.008) after adjusting for asthma. Pathway analysis highlighted hormone transport and MAPK signaling as potential mechanisms. Conclusion: Our findings provide genetic evidence supporting potential comorbidity‐independent causal links between specific systemic medications—particularly diabetes and thyroid drugs—and ocular complications, suggesting the importance of ophthalmological monitoring in these patients.

  • High fat diet-induced downregulation of TRPV2 mediates hepatic steatosis via p21 signalling

    by Pengfei Wei, Lixuan Li, Chenqiu Ran, Mingyue Jin, Huijuan Zhao, Kelaier Yang, Yu Wang, Huaqiu He, Mengyang Jia, Hongyan Pan, et al.

    The global prevalence and incidence of non-alcoholic fatty liver disease (NAFLD) are exhibiting an increasing trend. NAFLD is characterized by a significant accumulation of lipids, though its underlying mechanism is still unknown. Here we report that high-fat diet (HFD) feeding induced hepatic steatosis in mice, which was accompanied by a reduction in the expression and function of hepatic TRPV2. Moreover, conditional knockout of TRPV2 in hepatocytes exacerbated HFD-induced hepatic steatosis. In an in vitro model of NAFLD, TRPV2 regulated lipid accumulation in HepG2 cells, and TRPV2 activation inhibited the expression of the cellular senescence markers p21 and p16, all of which were mediated by AMPK phosphorylation. Finally, we found that administration of probenecid, a TRPV2 agonist, impaired HFD-induced hepatic steatosis and suppressed HFD-induced elevation in p21 and p16. Collectively, our findings imply that hepatic TRPV2 protects against the accumulation of lipids by modulating p21 signalling.


  • Integrated metabolomics analysis of the effect of PPARδ agonist GW501516 on catabolism of BCAAs and carboxylic acids in diabetic mice

    by Li Xiang, Juan Nie, Li Wang, Yu Wang, Jingchun Shi, Juntong Wei, Chi-Wai Lau, Zongwei Cai, Yu Huang